Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$69.51 - $104.43 $16,473 - $24,749
237 Added 3385.71%
244 $24,000
Q4 2021

Jan 31, 2022

SELL
$225.82 - $368.51 $21,001 - $34,271
-93 Reduced 93.0%
7 $2,000
Q3 2021

Oct 12, 2021

BUY
$221.9 - $484.47 $22,190 - $48,447
100 New
100 $38,000
Q2 2021

Jul 15, 2021

SELL
$129.91 - $234.98 $9,613 - $17,388
-74 Closed
0 $0
Q1 2021

May 03, 2021

BUY
$109.18 - $185.98 $8,079 - $13,762
74 New
74 $10,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.